genprowebdirectory
Facebook
Linkedin
RSS
Twitter
Youtube
GEN Edge
Featured News
Multimedia
News
Insights
Topics
Artificial Intelligence
Bioprocessing
Cancer
Drug Discovery
Genome Editing
Infectious Diseases
OMICs
Translational Medicine
Magazine
Browse Issues
Subscribe
Multimedia
Summits
Webinars
GEN Live
Learning Labs
Podcasts
Resources
A-Lists
eBooks/Perspectives
Tutorials
Peer-Reviewed Journals
GEN Biotechnology
Re:Gen Open
New Products
Conference Calendar
Subscribe
Get GEN Magazine
Get GEN eNewsletters
Search
Facebook
Linkedin
RSS
Twitter
Youtube
Sign in
Welcome! Log into your account
your username
your password
Forgot your password? Get help
Privacy Policy
Password recovery
Recover your password
your email
A password will be e-mailed to you.
GEN – Genetic Engineering and Biotechnology News
GEN Edge
Featured News
Multimedia
News
Insights
Topics
Artificial Intelligence
Bioprocessing
Cancer
Drug Discovery
Genome Editing
Infectious Diseases
OMICs
Translational Medicine
Magazine
Browse Issues
Subscribe
Multimedia
Summits
Webinars
GEN Live
Learning Labs
Podcasts
Resources
A-Lists
eBooks/Perspectives
Tutorials
Peer-Reviewed Journals
GEN Biotechnology
Re:Gen Open
New Products
Conference Calendar
Subscribe
Get GEN Magazine
Get GEN eNewsletters
Home
2008
Insomnia
News
Meda to Own Majority Stake in Newly Formed Joint Ventures with Valeant
News
GSK Inks $3.3B Deal for Rights to Actelion’s Insomnia Drug
News
Meda Inks $165M Deal to Commercialize Two Orexo Phase III Candidates
News
Researchers Reveal Mechanism of Circadian Rhythms
News
Dainippon Sumitomo Pharma Gains Japanese Rights to Neurocrine’s Insomnia Therapy in Deal Valued at over $30M
Insights
Acadias CNS Pipeline Propels Growth
News
Lundbeck’s Value Drops after Halt of Insomnia Drug Development with Merck & Co.
News
Ranbaxy Gets Ready to Penetrate Ambien’s $2B Market
News
Lilly to Acquire Sleep Disorder-Focused Company
News
Somaxon’s Insomnia Drug Shown to Be Effective in Phase III Trial
1
2
3
Page 3 of 3
Scroll Up
Scroll Up
